A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.
AUR-105 by Aurigene Oncology for Leukemia: Likelihood of Approval
AUR-105 is under clinical development by Aurigene Oncology and currently in Phase I for Leukemia.